![](/img/cover-not-exists.png)
(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study
Collignon, A., Houillier, C., Ahle, G., Chinot, O., Choquet, S., Schmitt, A., Agape, P., Soussain, C., Hoang-Xuan, K., Tabouret, EmelineLanguage:
english
Journal:
Annals of Hematology
DOI:
10.1007/s00277-018-3564-6
Date:
December, 2018
File:
PDF, 888 KB
english, 2018